While many money managers and pension funds are trimming their gold ETF holdings, John Paulson’s Paulson & Co. is going against the grain and holding a bullish take on gold. The hedge fund owns 10.2…
Today, shortly after the opening bell, Chanticleer Holdings announced its financial results for the three and nine months ended September 30, 2013. Significant Highlights: • On September 30, 2013, the company completed the acquisition of…
StemCells, a leading stem cell company currently developing novel cell-based therapeutics for disorders of the central nervous system, announced that Greg Schiffman has been recruited to join its executive team as Chief Financial Officer and…
Antares Pharma announced it has forged an exclusive promotion and marketing agreement with Denmark-based LEO Pharma to detail OTREXUP (methotrexate) to dermatologists for the symptomatic control of severe recalcitrant psoriasis in adults. Antares may receive…
Response Genetics, a company focused on molecular diagnostic testing services for cancer, announced the recent closing of new payor contracts with four national preferred provider organization (PPO) networks. These four new provider agreements are with…
OxySure Systems, a medical technology company focused on the design, manufacture, and distribution of specialty respiratory and medical solutions, today in its third-quarter financial and operating results posted its third consecutive quarter of triple-digit revenue…
Today, Calpian announced that, as of the end of October, the Money-on-Mobile service offered by its Indian subsidiary is now being supported by 167,145 retail locations, an increase of 4,069 stores from 163,076 stores just…
Nutrastar International, a China-based producer of premium branded consumer products, health beverages, and organic and specialty foods, reports its financial results for the three and nine months ended September 30, 2013. Revenues for the quarter…
Boston Therapeutics, a company focusing on the development of drugs using complex carbohydrate chemistry to address diabetes, reported in a news release today it is an exhibitor at the inaugural Obesity Week 2013 Conference in…
VistaGen Therapeutics, a biotechnology company, is blazing new trails by looking to the past. The company has developed a pioneering stem cell technology platform that can give a second chance to potentially lifesaving drugs that…
CAMAC Energy, who is focused on oil and gas E&P in Africa via their positions in The Gambia, Kenya, and in Nigeria via interest (30% WI) in a production sharing contract in the Oyo Oilfield,…
Ocean Power Technologies has developed what is arguably the most impressive utility-scale wave energy harvesting system on the market today, the PowerBuoy®, as an array deployable solution for producing hundreds of megawatts of endless clean…
Today before the opening bell, Chanticleer Holdings announced the closing of a private offering. Pursuant to the Subscription Agreement entered with three accredited investors, the Company sold an aggregate of 160,000 Units at a purchase…
Versar announced it has been awarded $8.8 million in subcontract extensions from HDR Environmental, Operations & Construction, Inc. to support continued construction management and quality assurance operations in Afghanistan. Supporting the Air Force’s construction responsibilities,…
Cardium Therapeutics is a health sciences and regenerative medicine company strategizing to acquire and develop new and innovative bio-medical product opportunities that have definable pathways to commercialization, partnering, sale, or other economic monetizations. To avoid…
Money-on-Mobile, a subsidiary of Calpian, Inc., was recently honored with two prestigious and highly competitive awards for its outstanding contributions in the area of mobile-based financial services. Founded in 2012, Money-on-Mobile is the largest mobile…
Lincoln Educational Services, a national leader in specialized technical training and supporter of students turning their passions into professional success, announced a scholarship opportunity specifically for veterans, as well as other service members of America’s…
Specialty pharmaceutical company Horizon Pharma announced that its Swiss subsidiary has signed an exclusive agreement with Mundipharma to commercialize and distribute LODOTRA in the Middle East and African regions. LODOTRA is an innovative delayed-release formulation…
Boston Therapeutics announced it has begun enrolling patients in a Phase 2b Trial for its PAZ320 drug today. A total of 24 patients with type 2 diabetes currently being treated with metformin will be administered…
Smith Micro Software, innovative supplier of solutions that simplify, secure, and enhance the mobile experience, announced today that Gemalto will now offer Smith’s NetWise™ solutions for network and device management to assist in the efficient…